Researchers from Purdue University and Merck & Co. have developed an innovative instrument to identify whether a potential drug has trace crystallinity, a factor that often makes potential medicines impractical for actual use. The device involves crushing powder made of the compound in question and detecting the light that’s produced, a technique known as triboluminescence.
Here’s a video report from Purdue about the research:
Study in Analytical Chemistry: Triboluminescence from Pharmaceutical Formulations…
Via: Purdue University…